Evidence map›Paper›PMID 33317543›Full record

ArticleJournal of neuroinflammation2020

Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases.

Gloria Biechele, Nicolai Franzmeier, Tanja Blume, Michael Ewers, Jose Medina Luque, Florian Eckenweber, Christian Sacher, Leonie Beyer, Francois Ruch-Rubinstein, Simon Lindner and 8 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Comparing and combining TSPO-PET tracers in tauopathies.European journal of nuclear medicine and molecular imaging · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. PET Imaging to Measure Neuroinflammation In Vivo.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 3 countries.

Gloria BiecheleDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninstraße 15, 81377, Munich, Germany.
Nicolai FranzmeierInstitute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.
Tanja BlumeDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninstraße 15, 81377, Munich, Germany.
Michael EwersInstitute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.
Jose Medina LuqueDZNE - German Center for Neurodegenerative Diseases, Munich, Germany.
Florian EckenweberDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninstraße 15, 81377, Munich, Germany.
Christian SacherDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninstraße 15, 81377, Munich, Germany.
Leonie BeyerDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninstraße 15, 81377, Munich, Germany.
Francois Ruch-RubinsteinDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninstraße 15, 81377, Munich, Germany.
Simon LindnerDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninstraße 15, 81377, Munich, Germany.
Franz-Josef GildehausDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninstraße 15, 81377, Munich, Germany.
Barbara von Ungern-SternbergDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninstraße 15, 81377, Munich, Germany.
Paul CummingDepartment of Nuclear Medicine, Inselspital, University Hospital Bern, Bern, Switzerland.
Peter BartensteinDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninstraße 15, 81377, Munich, Germany.
Axel RomingerDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninstraße 15, 81377, Munich, Germany.
Günter U HöglingerInstitute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.
Jochen HermsInstitute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.
Matthias BrendelDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninstraße 15, 81377, Munich, Germany. matthias.brendel@med.uni-muenchen.de.ORCID http://orcid.org/0000-0002-9247-2843
LMU Klinikum · DEGerman Center for Neurodegenerative Diseases · DELudwig-Maximilians-Universität München · DEMedizinische Hochschule Hannover · DEQueensland University of Technology · AUTechnical University of Munich · DEUniversity Hospital of Bern · CH

Funding

Deutsche Forschungsgemeinschaft BR4580/1-1Deutsche Forschungsgemeinschaft EXC 2145 SyNergyDeutsche Forschungsgemeinschaft RO5194/1-1
6 · The paper itself

Abstract

backgroundIn vivo assessment of neuroinflammation by 18-kDa translocator protein positron-emission-tomography (TSPO-PET) ligands receives growing interest in preclinical and clinical research of neurodegenerative disorders. Higher TSPO-PET binding as a surrogate for microglial activation in females has been reported for cognitively normal humans, but such effects have not yet been evaluated in rodent models of neurodegeneration and their controls. Thus, we aimed to investigate the impact of sex on microglial activation in amyloid and tau mouse models and wild-type controls.

methodsTSPO-PET (

resultsWild-type mice showed an increased TSPO-PET signal over time (female +23%, male +4%), with a significant sex × age interaction (T = - 4.171, p < 0.001). The Aβ model App

conclusionFemale mice indicate sex-dependent microglia activation in aging and in response to amyloidosis but not in response to tau pathology. This calls for consideration of sex difference in TSPO-PET studies of microglial activation in mouse models of neurodegeneration and by extension in human studies.

Indexed as

Disease Models, AnimalSex CharacteristicsAgingAmyloidosisAnimalsFemaleMaleMiceMice, Inbred C57BLMice, TransgenicNeurodegenerative DiseasesNeurogliaPositron-Emission Tomographytau ProteinsMapt protein, mousetau ProteinsAmyloidMicrogliaSexTauTSPO

Identifiers

PMID33317543
PMCPMC7737385
OpenAlexW3111081483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.